Quantitative Systematic Strategies LLC Gossamer Bio, Inc. Transaction History

Quantitative Systematic Strategies LLC

  • $0
  • Q3 2022

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 09, 2021
SELL
$8.3 - $13.59 $316,918 - $518,906
-38,183 Closed
0 $0
Q3 2020

Nov 09, 2020
BUY
$11.3 - $14.75 $17,989 - $23,482
1,592 Added 4.35%
38,183 $474,000
Q2 2020

Aug 04, 2020
BUY
$9.52 - $15.98 $348,346 - $584,724
36,591 New
36,591 $476,000
Q1 2020

May 06, 2020
SELL
$8.0 - $15.48 $87,856 - $170,001
-10,982 Closed
0 $0
Q4 2019

Feb 11, 2020
BUY
$14.82 - $26.79 $162,753 - $294,207
10,982 New
10,982 $172,000

Others Institutions Holding GOSS

# of Institutions
108
Shares Held
167M
Call Options Held
430K
Put Options Held
519K
View Full List

About Gossamer Bio, Inc.

GOSS Quotes by TradingView
  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $80.8M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Quantitative Systematic Strategies LLC Portfolio

Follow Quantitative Systematic Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email